NASDAQ:AMAG
Delisted
AMAG Pharmaceuticals Stock News
$13.75
+0 (+0%)
At Close: May 27, 2022
Stem Cell & Regenerative Medicine Market : Emerging Trends, Highlights and Challenges ...
12:00am, Thursday, 05'th Mar 2020Why AMAG Pharmaceuticals Struggled Again in Q4
07:00pm, Wednesday, 04'th Mar 2020
The drugmaker had more bad news than good news in its latest quarterly update.
AMAG Pharmaceuticals Inc (AMAG) Q4 2019 Earnings Call Transcript
06:30pm, Wednesday, 04'th Mar 2020
AMAG earnings call for the period ending December 31, 2019.
AMAG Pharmaceuticals, Inc. (AMAG) CEO Bill Heiden on Q4 2019 Results - Earnings Call Transcript
06:02pm, Wednesday, 04'th Mar 2020
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Q4 2019 Results Conference Call March 04, 2020 08:00 AM ET Company Participants Linda Lennox - VP, IR Bill Heiden - Pre
AMAG Pharma Chief Medical Officer Julie Krop to Step Down
04:26pm, Wednesday, 04'th Mar 2020
Julie Krop, chief medical officer of AMAG Pharmaceuticals (NASDAQ: ]) since 2015, is leaving at the end of the month, the Waltham, MA-based company
AMAG Pharmaceuticals (AMAG) Reports Q4 Loss, Tops Revenue Estimates
01:35pm, Wednesday, 04'th Mar 2020
AMAG Pharmaceuticals (AMAG) delivered earnings and revenue surprises of -2.94% and 1.57%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
AMAG Pharmaceuticals (AMAG) Reports Q4 Loss, Tops Revenue Estimates
01:35pm, Wednesday, 04'th Mar 2020
AMAG Pharmaceuticals (AMAG) delivered earnings and revenue surprises of -2.94% and 1.57%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
AMAG Pharma +5% premarket on Q4 results
01:06pm, Wednesday, 04'th Mar 2020
AMAG Pharmaceuticals (AMAG) Q4 results:Revenues: $89.7M (+1.8%); Feraheme: $41.7M (+18.5%); Makena: $25.6M (-45.4%); Intrarosa: $6.5M (+10.2%).Net loss: ($199.9M); loss/share: ($5.89); CF Ops: ($125.7
BRIEF-AMAG Pharmaceuticals Reports Qtrly Loss Per Share $5.89
12:46pm, Wednesday, 04'th Mar 2020
AMAG Pharmaceuticals Inc:
AMAG Pharmaceuticals: 4Q Earnings Snapshot
12:43pm, Wednesday, 04'th Mar 2020
WALTHAM, Mass. (AP) _ AMAG Pharmaceuticals Inc. (AMAG) on Wednesday reported a loss of $199.9 million in its fourth quarter. On a per-share basis, the Waltham, Massachusetts-based company said it had
AMAG Pharmaceuticals: 4Q Earnings Snapshot
12:42pm, Wednesday, 04'th Mar 2020
WALTHAM, Mass. (AP) _ AMAG Pharmaceuticals Inc. (AMAG) on Wednesday reported a loss of $199.9 million in its fourth quarter.
On a per-share basis, the Waltham, Massachusetts-based company said it had
The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies
12:37pm, Wednesday, 04'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 3) Acceleron Pharma Inc (NASDAQ: XLRN ) BioMarin Phar
BRIEF-AMAG Pharmaceuticals Says Julie Krop, Executive Vice President & Chief Medical Officer, Will Be Leaving Co
12:34pm, Wednesday, 04'th Mar 2020
AMAG Pharmaceuticals Inc:
AMAG Pharmaceuticals (AMAG) Q3 2019 Earnings Snapshot | AlphaStreet
12:17pm, Wednesday, 04'th Mar 2020
AMAG Pharmaceuticals (NASDAQ: AMAG) reported a net loss of $199.9 million or $5.89 per share for the fourth quarter of 2019 vs. $0.36 per share loss expected.
AMAG Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
12:00pm, Wednesday, 04'th Mar 2020
WALTHAM, Mass., March 04, 2020 -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today reported unaudited consolidated financial results for the fourth quarter and full year ended.
